Bayer Canada

A Life Science Company

read more
A Life Science Company

Explore Your Topic

Latest News

Share Price/Index

Local News

October 16, 2019

Updated analysis for larotrectinib confirms high response rate and durable responses over three years in children and adults with TRK fusion cancer

79% overall response rate (ORR) in 153 evaluable adult and pediatric patients at time of new data cut off (February 19, 2019); results consistent with previous publications / Similar ORR of 75% in patients with brain metastases1, adding to the previously reported evidence for larotrectinib’s activity in central nervous system (CNS) / Median progression free survival (mPFS) of 28.3 months and median overall survival (mOS) of more than three years (44.4 months) was achieved; median duration of response (mDOR) of nearly three years1 / Largest dataset with longest follow-up of any TRK inhibitor illustrates favourable safety profile across ages and tumour types Read more
October 02, 2019

Bayer Fund shares over $100,000 in funding with students through its Opportunity Scholarship Program

67 Canadian students pursuing post-secondary education in agriculture and food-related disciplines Read more
September 03, 2019

Bayer completes sale of iconic Coppertone™ brand to Beiersdorf

Divestiture enables Bayer to focus on core OTC business Read more
Bayer News Overview

Global News

October 01, 2019

Ertharin Cousin to become member of Bayer AG Supervisory Board

Read more

Advance Your Career

Jobs at Bayer Canada

  • Interested in working for us? See if there are job openings in Canada.

  • read more

Our Businesses

We research, develop and market innovative products that improve the health of people, plants and animals. Our business comprises three core divisions and two business units. Learn more about it here.

Last updated: January 02, 2019